Lipoprotein(a): the underutilized risk factor for cardiovascular disease.


Journal

Global cardiology science & practice
ISSN: 2305-7823
Titre abrégé: Glob Cardiol Sci Pract
Pays: Qatar
ID NLM: 101613130

Informations de publication

Date de publication:
20 Sep 2019
Historique:
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 5 12 2019
Statut: epublish

Résumé

Raised lipoprotein(a) [Lp(a)] is an important independent cardiovascular risk factor and predictor of adverse outcomes. Challenges remain with regards to the screening, diagnosis and management of this condition. Although further prospective randomised controlled data is required, there is growing evidence suggesting that lowering Lp(a) may reduce the risk of cardiovascular events and ameliorate symptoms.

Identifiants

pubmed: 31799286
doi: 10.21542/gcsp.2019.11
pii: gcsp.2019.11
pmc: PMC6865184
doi:

Types de publication

News

Langues

eng

Pagination

e201911

Informations de copyright

Copyright ©2019 The Author(s).

Déclaration de conflit d'intérêts

All authors confirm that they have no competing interests to declare.

Références

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3058-65
pubmed: 23065826
N Engl J Med. 2014 Jul 17;371(3):203-12
pubmed: 25014686
Circulation. 2008 Jan 15;117(2):176-84
pubmed: 18086931
Mayo Clin Proc. 2013 Nov;88(11):1294-311
pubmed: 24182706
J Lipid Res. 2016 Oct;57(10):1751-1757
pubmed: 26889050
Eur Heart J. 2010 Dec;31(23):2844-53
pubmed: 20965889
J Am Coll Cardiol. 2014 Apr 8;63(13):1278-1288
pubmed: 24509273
Eur Heart J. 2017 May 21;38(20):1530-1532
pubmed: 30052891
Transfus Apher Sci. 2009 Aug;41(1):61-5
pubmed: 19540812
Circulation. 2013 Dec 17;128(24):2567-76
pubmed: 24056686
JAMA. 2009 Jul 22;302(4):412-23
pubmed: 19622820
Clin Chem. 2000 Dec;46(12):1956-67
pubmed: 11106328
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Lancet. 2016 Nov 5;388(10057):2239-2253
pubmed: 27665230
Glob Cardiol Sci Pract. 2015 Jul 07;2015(2):28
pubmed: 26779510
Circulation. 2000 Sep 5;102(10):1082-5
pubmed: 10973834
Acta Pathol Microbiol Scand. 1963;59:369-82
pubmed: 14064818
Pharmacol Ther. 2010 Jun;126(3):314-45
pubmed: 20153365
Clin Chem Lab Med. 2004;42(6):670-6
pubmed: 15259385
Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):229-39
pubmed: 19234501
Eur J Clin Invest. 1994 Jul;24(7):444-53
pubmed: 7957500
Eur Heart J. 2017 May 21;38(20):1561-1569
pubmed: 28453721
Circulation. 2014 Feb 11;129(6):635-42
pubmed: 24243886
Lancet. 2015 Oct 10;386(10002):1472-83
pubmed: 26210642

Auteurs

T Z Khan (TZ)

Harefield Hospital, Royal Brompton & Harefield NHS Foundation Trust Hospital, Hill End Road, Harefield UB9 6JH, United Kingdom.

S R Bornstein (SR)

University Hospital Carl Gustav Carus, Fetscher Street 74, Dresden 01307, Germany.

M Barbir (M)

Harefield Hospital, Royal Brompton & Harefield NHS Foundation Trust Hospital, Hill End Road, Harefield UB9 6JH, United Kingdom.

Classifications MeSH